{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q96PG8",
      "entity_text" : "BBC3",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P10415",
      "entity_text" : "Bcl-2",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Furthermore, western blot analysis indicated that compared with those in the control and miR-NC inhibitor groups, miR-222 inhibitor decreased the protein levels of Bcl-2 / cyclin D1 and increased BBC3 / cleaved caspase-3 protein levels in HepG2 cells (XREF_FIG).",
  "reading_complete" : "2020-08-02T13:19:51Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:18:47Z",
  "trigger" : "increased",
  "evidence" : [ "Bcl-2/cyclin D1 and increased BBC3" ],
  "pmc_id" : "5979783",
  "score" : 0
}